Intervention not reported
Serious adverse events at longest · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention showed no clear difference in serious adverse events at longest (low certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of adults with COVID‐19 2023 · Cochrane Headline outcomes onlyPeto OR 1.57 [0.48, 5.14]1 study · 1815 participantsLow